These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 29393411)
1. Bu-Fei decoction and modified Bu-Fei decoction inhibit the growth of non-small cell lung cancer, possibly via inhibition of apurinic/apyrimidinic endonuclease 1. Jiang ST; Han SY; Pang LN; Jiao YN; He XR; Li PP Int J Mol Med; 2018 Apr; 41(4):2128-2138. PubMed ID: 29393411 [TBL] [Abstract][Full Text] [Related]
2. Bu Fei Decoction attenuates the tumor associated macrophage stimulated proliferation, migration, invasion and immunosuppression of non-small cell lung cancer, partially via IL-10 and PD-L1 regulation. Pang L; Han S; Jiao Y; Jiang S; He X; Li P Int J Oncol; 2017 Jul; 51(1):25-38. PubMed ID: 28534943 [TBL] [Abstract][Full Text] [Related]
3. Chinese medicine Bu-Fei decoction attenuates epithelial-mesenchymal transition of non-small cell lung cancer via inhibition of transforming growth factor β1 signaling pathway in vitro and in vivo. He XR; Han SY; Li XH; Zheng WX; Pang LN; Jiang ST; Li PP J Ethnopharmacol; 2017 May; 204():45-57. PubMed ID: 28412214 [TBL] [Abstract][Full Text] [Related]
4. Prediction of survival prognosis of non-small cell lung cancer by APE1 through regulation of Epithelial-Mesenchymal Transition. Wei X; Li Q; Li Y; Duan W; Huang C; Zheng X; Sun L; Luo J; Wang D; Zhang S; Xin X; Gao M Oncotarget; 2016 May; 7(19):28523-39. PubMed ID: 27074577 [TBL] [Abstract][Full Text] [Related]
5. Modified Bu-Fei decoction inhibits lung metastasis via suppressing angiopoietin-like 4. Hao H; Guo Z; Li Z; Li J; Jiang S; Fu J; Jiao Y; Deng X; Han S; Li P Phytomedicine; 2022 Nov; 106():154409. PubMed ID: 36070661 [TBL] [Abstract][Full Text] [Related]
6. Small-molecule BH3 mimetic and pan-Bcl-2 inhibitor AT-101 enhances the antitumor efficacy of cisplatin through inhibition of APE1 repair and redox activity in non-small-cell lung cancer. Ren T; Shan J; Li M; Qing Y; Qian C; Wang G; Li Q; Lu G; Li C; Peng Y; Luo H; Zhang S; Yang Y; Cheng Y; Wang D; Zhou SF Drug Des Devel Ther; 2015; 9():2887-910. PubMed ID: 26089640 [TBL] [Abstract][Full Text] [Related]
7. Human apurinic/apyrimidinic endonuclease siRNA inhibits the angiogenesis induced by X-ray irradiation in lung cancer cells. Gu X; Cun Y; Li M; Qing Y; Jin F; Zhong Z; Dai N; Qian C; Sui J; Wang D Int J Med Sci; 2013; 10(7):870-82. PubMed ID: 23781133 [TBL] [Abstract][Full Text] [Related]
8. Knock down of the dual functional protein apurinic /apyrimidinic endonuclease 1 enhances the killing effect of hematoporphrphyrin derivative-mediated photodynamic therapy on non-small cell lung cancer cells in vitro and in a xenograft model. Yang ZZ; Li MX; Zhang YS; Xiang DB; Dai N; Zeng LL; Li ZP; Wang G; Wang D Cancer Sci; 2010 Jan; 101(1):180-7. PubMed ID: 19860842 [TBL] [Abstract][Full Text] [Related]
9. Traditional Chinese medicine Ze-Qi-Tang formula inhibit growth of non-small-cell lung cancer cells through the p53 pathway. Xu Z; Zhang F; Zhu Y; Liu F; Chen X; Wei L; Zhang N; Zhou Q; Zhong H; Yao C; Zhu X; Gong C; Zhu S; Zou C J Ethnopharmacol; 2019 Apr; 234():180-188. PubMed ID: 30660711 [TBL] [Abstract][Full Text] [Related]
10. Cytoplasmic Ape1 expression elevated by p53 aberration may predict survival and relapse in resected non-small cell lung cancer. Wu HH; Chu YC; Wang L; Tsai LH; Lee MC; Chen CY; Shieh SH; Cheng YW; Lee H Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S336-47. PubMed ID: 22688662 [TBL] [Abstract][Full Text] [Related]
11. APE1 overexpression is associated with cisplatin resistance in non-small cell lung cancer and targeted inhibition of APE1 enhances the activity of cisplatin in A549 cells. Wang D; Xiang DB; Yang XQ; Chen LS; Li MX; Zhong ZY; Zhang YS Lung Cancer; 2009 Dec; 66(3):298-304. PubMed ID: 19324449 [TBL] [Abstract][Full Text] [Related]
12. The regulatory role of APE1 in epithelial-to-mesenchymal transition and in determining EGFR-TKI responsiveness in non-small-cell lung cancer. Yang X; Peng Y; Jiang X; Lu X; Duan W; Zhang S; Dai N; Shan J; Feng Y; Li X; Cheng Y; Yang Y; Baugh L; Tell G; Wang D; Li M Cancer Med; 2018 Sep; 7(9):4406-4419. PubMed ID: 30109782 [TBL] [Abstract][Full Text] [Related]
13. APE1 shRNA-loaded cancer stem cell-derived extracellular vesicles reverse Erlotinib resistance in non-small cell lung cancer via the IL-6/STAT3 signalling. Tang CH; Qin L; Gao YC; Chen TY; Xu K; Liu T; Ren T Clin Transl Med; 2022 May; 12(5):e876. PubMed ID: 35605028 [TBL] [Abstract][Full Text] [Related]
14. The repression and reciprocal interaction of DNA methyltransferase 1 and specificity protein 1 contributes to the inhibition of MET expression by the combination of Chinese herbal medicine FZKA decoction and erlotinib. Zheng F; Zhao Y; Li X; Tang Q; Wu J; Wu W; Hann SS J Ethnopharmacol; 2019 Jul; 239():111928. PubMed ID: 31077779 [TBL] [Abstract][Full Text] [Related]
15. Reduced apurinic/apyrimidinic endonuclease activity enhances the antitumor activity of oxymatrine in lung cancer cells. Wang Z; Xu W; Lin Z; Li C; Wang Y; Yang L; Liu G Int J Oncol; 2016 Dec; 49(6):2331-2340. PubMed ID: 27748797 [TBL] [Abstract][Full Text] [Related]
16. APE1 stimulates EGFR-TKI resistance by activating Akt signaling through a redox-dependent mechanism in lung adenocarcinoma. Lu GS; Li M; Xu CX; Wang D Cell Death Dis; 2018 Oct; 9(11):1111. PubMed ID: 30382076 [TBL] [Abstract][Full Text] [Related]
17. Combination of Gentiana rhodantha and Gerbera anandria in the BL02 formula as therapeutics to non-small cell lung carcinoma acting via Rap1/cdc42 signaling: A transcriptomics/ bio-informatics biological validation approach. Tan HY; Ho VW; Chan YT; Zhang C; Wang N; Xia W; Feng Y Pharmacol Res; 2020 May; 155():104415. PubMed ID: 31465829 [TBL] [Abstract][Full Text] [Related]